Kamino

Kamino is a Danish biotechnology company focused on developing a novel drug delivery platform based on extracellular matrix (ECM) binding compounds. The company's technology utilizes specific peptide and protein compositions designed for the localized loading and sustained release of therapeutic or diagnostic agents at target tissue sites. By leveraging the structural and biochemical properties of the ECM, Kamino aims to enhance the efficacy and safety of treatments in areas such as oncology and regenerative medicine. The company is a research-driven entity with intellectual property centered on bioinspired wet adhesion and targeted delivery mechanisms.